Smith & Nephew revenue was £3.72 b in FY, 2018 which is a (2.9%) year over year increase from the previous period.
|FY, 1996||FY, 1997||FY, 1998||FY, 1999||FY, 2000||FY, 2001||FY, 2002||FY, 2003||FY, 2004||FY, 2005||FY, 2006||FY, 2007||FY, 2013||FY, 2014||FY, 2015||FY, 2016||FY, 2017||FY, 2018|
|Revenue||£1.07 b||£1.05 b||£1.05 b||£1.12 b||£1.13 b||£1.08 b||£1.11 b||£1.18 b||£1.25 b||£1.41 b||£1.42 b||£2.04 b||£2.87 b||£3.17 b||£3.58 b||£3.39 b||£3.61 b||£3.72 b|
Smith & Nephew revenue breakdown by business segment: 12.9% from Sports Medicine Joint Repair , 13.9% from Arthroscopic Enabling Technologies , 9.9% from Trauma & Extremities, 19.8% from Knee Implants, 12.9% from Hip Implants, 14.9% from Advanced Wound Care, 6.9% from Advanced Wound Bioactives and 8.9% from Other
|Advanced Wound Devices||4|
|Sports Medicine Joint Repair||13|
|Arthroscopic Enabling Technologies||14|
|Trauma & Extremities||10|
|Other Surgical Businesses||5|
|Advanced Wound Care||15|
|Advanced Wound Bioactives||7|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.